We are live on ! Find out more

Progyny

PGNY

Market cap $2.2B

28.68 USD

+0.10

0.35%

At close Updated Oct 21, 2:05 PM EDT

1 day

0.35%

5 days

3.28%

1 month

6.78%

3 months

-11.04%

6 months

59.16%

Year to date

11.42%

1 year

47.76%

5 years

-53.19%

10 years

79.92%

About: Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Employees: 856

Healthcare Healthcare Plans

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 45%

Neutral 50%

Negative 5%

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30, 2026, after the close of the market on Wednesday, November 4, 2026.

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, announced today that it will present new research evaluating real-world outcomes from its Menopause and Midlife program and exhibit at The Menopause Society 2026 Annual Meeting in San Diego, October 20 – 24, 2026.

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Zacks Investment Research

Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?

Progyny (PGNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?

Zacks Investment Research

PGNY or CRL: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Progyny (PGNY) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for undervalued stocks?

PGNY or CRL: Which Is the Better Value Stock Right Now?

Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics

Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions Reflects How Employers are Increasingly Turning to Solutions with a Proven Track Record of Delivering Savings, Total Cost Management and ROI Progyny's Solutions Creating Compelling Opportunities for Employers to Stem Impacts from Broader Medical Cost Inflation Trend While Maintaining or Expanding Coverage of Services Impactful to their Workforce NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today revealed key insights from the Company's current annual selling season, based on both commitments received to date and anticipated remaining decisions which are expected to contribute 1.2 million new covered lives from launches throughout the first half of 2027. Employers are now weighing how to best meet the complex needs of their workforce while simultaneously wrestling with the broader escalation in the overall medical cost trend.

Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics

Zacks Investment Research

PGNY vs. CRL: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Progyny (PGNY) or Charles River Laboratories (CRL). But which of these two stocks presents investors with the better value opportunity right now?

PGNY vs. CRL: Which Stock Is the Better Value Option?

Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027

Progyny (PGNY) remains the US market leader in fertility benefits management, demonstrating robust growth, improving margins, and a compelling valuation despite recent volatility. PGNY's Q2 2026 results highlight 11% revenue growth ex-Amazon, margin expansion, and nearly 100% EPS growth guidance for 2026, supporting a continued buy rating. Secular tailwinds—rising infertility rates, delayed family formation, and underpenetrated employer markets—position PGNY for sustained double-digit growth and market share gains.

Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027

Zacks Investment Research

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know

The mean of analysts' price targets for Progyny (PGNY) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA on Tuesday, September 8, 2026, at 11:00 a.m. ET.

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

Zacks Investment Research

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns

MNDY, MTCH, PGNY and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns

See News Rankings

Price charts implemented using Lightweight Charts™